Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retinal debris triggers cytotoxic damage in cocultivated primary porcine RPE cells. | Front Neurosci | 2024 | 39114482 | PubTator, text mining | PubMed |
| Effect of Pulsed Low-Level Lasers on Adult versus Neonatal Human Retinal Pigment Epithelial Cells: An in-vitro Study. | J Ophthalmic Vis Res | 2024 | 39055499 | PubTator, text mining | PubMed |
| Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65. | Gene Ther | 2024 | 38997420 | PubTator, text mining | PubMed |
| PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics. | Nat Commun | 2024 | 38942756 | PubTator, text mining | PubMed |
| Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector. | Transl Vis Sci Technol | 2024 | 38888288 | PubTator, text mining | PubMed |
| Strategies for enhanced gene delivery to the central nervous system. | Nanoscale Adv | 2024 | 38868835 | PubTator, text mining | PubMed |
| Ablation of Fatty Acid Transport Protein-4 Enhances Cone Survival, M-cone Vision, and Synthesis of Cone-Tropic 9-cis-Retinal in rd12 Mouse Model of Leber Congenital Amaurosis. | J Neurosci | 2024 | 38811164 | PubTator, text mining | PubMed |
| The Effects of the Coating and Aging of Biodegradable Polylactic Acid Membranes on In Vitro Primary Human Retinal Pigment Epithelium Cells. | Biomedicines | 2024 | 38790928 | PubTator, text mining | PubMed |
| Clinical and genetic studies for a cohort of patients with Leber congenital amaurosis. | Graefes Arch Clin Exp Ophthalmol | 2024 | 38662103 | PubTator, text mining | PubMed |
| Generation of two induced pluripotent stem cell lines (LVPEIi004-A and LVPEIi005-A) from probands with Leber Congenital Amaurosis 2 (LCA2) and harboring mutations in RPE65. | Stem Cell Res | 2024 | 38631180 | PubTator, text mining | PubMed |
| Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice. | Eye (Lond) | 2024 | 38627549 | PubTator, text mining | PubMed |
| Exome sequencing and genome-wide association analyses unveils the genetic predisposition in hydroxychloroquine retinopathy. | Eye (Lond) | 2024 | 38548946 | PubTator, text mining | PubMed |
| Color fundus imaging: The backbone of our journey in genotype-phenotype correlation. | Indian J Ophthalmol | 2024 | 38546475 | PubTator, text mining | PubMed |
| Central visual pathways affected by degenerative retinal disease before and after gene therapy. | Brain | 2024 | 38538211 | PubTator, text mining | PubMed |
| Precision ophthalmology: a call for Africa not to be left in the dark. | Gene Ther | 2024 | 38519591 | PubTator, text mining | PubMed |
| A Mild Form of RPE65-Associated Retinopathy. | Klin Monbl Augenheilkd | 2024 | 38508216 | PubTator, text mining | PubMed |
| RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec. | Klin Monbl Augenheilkd | 2024 | 38508214 | PubTator, text mining | PubMed |
| Carotenoid cleavage enzymes evolved convergently to generate the visual chromophore. | Nat Chem Biol | 2024 | 38355721 | PubTator, text mining | PubMed |
| RPE65 mutations in Leber congenital amaurosis, early-onset severe retinal dystrophy, and retinitis pigmentosa from a tertiary eye care center in India. | Ophthalmic Genet | 2024 | 38323530 | PubTator, text mining | PubMed |
| Could internal limiting membrane peeling before Voretigen neparvovec-ryzl subretinal injection prevent focal chorioretinal atrophy? | Heliyon | 2024 | 38322949 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=9